首页 > 最新文献

Indian Journal of Ophthalmology最新文献

英文 中文
Portable devices are the way forward! 便携式设备是前进的方向!
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_2762_25
Karthikeyan Mahalingam, Geeta Behera
{"title":"Portable devices are the way forward!","authors":"Karthikeyan Mahalingam, Geeta Behera","doi":"10.4103/IJO.IJO_2762_25","DOIUrl":"10.4103/IJO.IJO_2762_25","url":null,"abstract":"","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"460"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002225/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283517","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety and efficacy of triple procedures in pseudoexfoliation glaucoma and intraocular lens (IOL) subluxation: IOL extraction, Yamane Technique, and gonioscopy-assisted transluminal trabeculotomy. 三联手术治疗假脱落性青光眼和人工晶状体半脱位的安全性和有效性:人工晶状体摘除、Yamane技术和腔镜辅助小梁切开术。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_2176_25
Caglar Bektas, Erdem Yuksel

Purpose: To evaluate the safety and efficacy of a combined surgical approach involving intraocular lens (IOL) explantation, flanged intrascleral IOL fixation using the Yamane technique, and gonioscopy-assisted transluminal trabeculotomy (GATT) in patients with dislocated IOLs and pseudoexfoliative glaucoma.

Design: Retrospective observational study.

Methods: This single-center study included 15 patients (15 eyes) with dislocated IOLs and pseudoexfoliative glaucoma who underwent combined IOL exchange (Yamane technique) and GATT, with a minimum 3-month follow-up. Inclusion criteria were uncontrolled IOP (>21 mmHg) or progressive glaucomatous damage. Main outcome measures included changes in IOP and antiglaucomatous medications (AGMs), surgical success, and complications.

Results: The mean preoperative IOP decreased from 29.40 ± 3.40 mmHg to 14.80 ± 1.52 mmHg (P < 0.001), and the mean number of AGMs reduced from 3.47 ± 0.83 to 1.13 ± 0.83 (P < 0.001) at a mean follow-up of 14.67 ± 6.10 months. The best corrected visual acuity improved significantly (P < 0.001), while ganglion cell layer and retinal nerve fiber layer thicknesses remained stable. Complete surgical success was achieved in 26.7% of eyes, and qualified success in all cases. The overall complication rate was 60%; the most common complications were microhyphema and mild vitreous hemorrhage, occurring in four patients each (26.7%), all of which resolved spontaneously.

Conclusions: Combined flanged intrascleral IOL fixation and GATT is an effective, minimally invasive strategy with an acceptable safety profile for IOP reduction and IOL exchange in patients with dislocated IOLs and pseudoexfoliative glaucoma, with the advantage of preserving the conjunctiva for future interventions.

目的:评价人工晶状体(IOL)植入术、斜缘巩膜内人工晶状体(IOL) Yamane技术内固定、镜下辅助腔内小梁切开术(GATT)联合手术治疗人工晶状体脱位合并假剥脱性青光眼的安全性和有效性。设计:回顾性观察性研究。方法:本研究纳入15例(15眼)人工晶状体脱位合并假剥脱性青光眼患者,接受联合人工晶状体置换术(Yamane技术)和GATT,随访至少3个月。纳入标准为眼压未控制(眼压低于21毫米汞柱)或进行性青光眼损害。主要结局指标包括IOP和抗青光眼药物(AGMs)的变化、手术成功率和并发症。结果:平均随访14.67±6.10个月,术前平均IOP由29.40±3.40 mmHg降至14.80±1.52 mmHg (P < 0.001),平均agm数由3.47±0.83降至1.13±0.83 (P < 0.001)。最佳矫正视力显著提高(P < 0.001),而神经节细胞层和视网膜神经纤维层厚度保持稳定。26.7%的眼睛手术完全成功,所有病例均获得合格的手术成功。总并发症发生率为60%;最常见的并发症是小前房积血和轻度玻璃体出血,各发生4例(26.7%),均自行消退。结论:对于人工晶状体脱位和假剥脱性青光眼患者的IOP复位和人工晶状体置换术,联合带缘巩膜内人工晶状体固定和GATT是一种有效的微创策略,具有可接受的安全性,并具有保留结膜以供未来干预的优势。
{"title":"Safety and efficacy of triple procedures in pseudoexfoliation glaucoma and intraocular lens (IOL) subluxation: IOL extraction, Yamane Technique, and gonioscopy-assisted transluminal trabeculotomy.","authors":"Caglar Bektas, Erdem Yuksel","doi":"10.4103/IJO.IJO_2176_25","DOIUrl":"10.4103/IJO.IJO_2176_25","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the safety and efficacy of a combined surgical approach involving intraocular lens (IOL) explantation, flanged intrascleral IOL fixation using the Yamane technique, and gonioscopy-assisted transluminal trabeculotomy (GATT) in patients with dislocated IOLs and pseudoexfoliative glaucoma.</p><p><strong>Design: </strong>Retrospective observational study.</p><p><strong>Methods: </strong>This single-center study included 15 patients (15 eyes) with dislocated IOLs and pseudoexfoliative glaucoma who underwent combined IOL exchange (Yamane technique) and GATT, with a minimum 3-month follow-up. Inclusion criteria were uncontrolled IOP (>21 mmHg) or progressive glaucomatous damage. Main outcome measures included changes in IOP and antiglaucomatous medications (AGMs), surgical success, and complications.</p><p><strong>Results: </strong>The mean preoperative IOP decreased from 29.40 ± 3.40 mmHg to 14.80 ± 1.52 mmHg (P < 0.001), and the mean number of AGMs reduced from 3.47 ± 0.83 to 1.13 ± 0.83 (P < 0.001) at a mean follow-up of 14.67 ± 6.10 months. The best corrected visual acuity improved significantly (P < 0.001), while ganglion cell layer and retinal nerve fiber layer thicknesses remained stable. Complete surgical success was achieved in 26.7% of eyes, and qualified success in all cases. The overall complication rate was 60%; the most common complications were microhyphema and mild vitreous hemorrhage, occurring in four patients each (26.7%), all of which resolved spontaneously.</p><p><strong>Conclusions: </strong>Combined flanged intrascleral IOL fixation and GATT is an effective, minimally invasive strategy with an acceptable safety profile for IOP reduction and IOL exchange in patients with dislocated IOLs and pseudoexfoliative glaucoma, with the advantage of preserving the conjunctiva for future interventions.</p>","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"403-408"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002015/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283580","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Laser peripheral iridotomy induced changes in eyes with primary angle closure disease. 激光周围虹膜切开术致原发性闭角病眼的改变。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_1474_25
Srinivasan Kavitha, Nazlee Zebardast, S Swetha, Mona Khurana, Shweta Tripathi, S Usha Tejaswini, Yapei Zhang, Rengaraj Venkatesh

Primary angle closure disease (PACD) though less prevalent than primary open angle glaucoma contributes to fifty percent of glaucoma blindness, particularly in the Asian population. Pupillary block is the most common pathology associated with PACD. The definitive treatment to relieve pupillary block and to prevent disease progression is laser peripheral iridotomy (LPI). The most commonly employed laser for performing laser peripheral iridotomy is Neodymium: Yttrium Aluminium Garnet (Nd:YAG). LPI is routinely performed as an outpatient procedure. Though it is often considered as a safe procedure, it is not without limitations. Apart from widening the angle it can influence the intraocular pressure, corneal endothelial cells and can lead to newer visual disturbances/dysphotopsias. Additionally, it can cause or accelerate cataract formation. This narrative review discusses the indications, procedural considerations, structural and functional outcomes, and the changes associated with LPI in eyes with PACD.

原发性闭角型青光眼发病率虽低于原发性开角型青光眼,但仍占青光眼致盲的50%,尤其在亚洲人群中。瞳孔阻滞是与PACD相关的最常见的病理。缓解瞳孔阻滞和预防疾病进展的最终治疗是激光周围虹膜切开术(LPI)。最常用的激光进行激光周围虹膜切开术是钕钇铝石榴石(Nd:YAG)。LPI通常作为门诊手术进行。虽然它通常被认为是一种安全的程序,但它并非没有局限性。除了使角度变宽外,它还会影响眼压、角膜内皮细胞,并可导致新的视力障碍/视力障碍。此外,它还会导致或加速白内障的形成。这篇叙述性的综述讨论了适应症、手术注意事项、结构和功能结果,以及与PACD眼部LPI相关的变化。
{"title":"Laser peripheral iridotomy induced changes in eyes with primary angle closure disease.","authors":"Srinivasan Kavitha, Nazlee Zebardast, S Swetha, Mona Khurana, Shweta Tripathi, S Usha Tejaswini, Yapei Zhang, Rengaraj Venkatesh","doi":"10.4103/IJO.IJO_1474_25","DOIUrl":"10.4103/IJO.IJO_1474_25","url":null,"abstract":"<p><p>Primary angle closure disease (PACD) though less prevalent than primary open angle glaucoma contributes to fifty percent of glaucoma blindness, particularly in the Asian population. Pupillary block is the most common pathology associated with PACD. The definitive treatment to relieve pupillary block and to prevent disease progression is laser peripheral iridotomy (LPI). The most commonly employed laser for performing laser peripheral iridotomy is Neodymium: Yttrium Aluminium Garnet (Nd:YAG). LPI is routinely performed as an outpatient procedure. Though it is often considered as a safe procedure, it is not without limitations. Apart from widening the angle it can influence the intraocular pressure, corneal endothelial cells and can lead to newer visual disturbances/dysphotopsias. Additionally, it can cause or accelerate cataract formation. This narrative review discusses the indications, procedural considerations, structural and functional outcomes, and the changes associated with LPI in eyes with PACD.</p>","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"323-331"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002023/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on: Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial. 评论:小梁切除术后使用2.0%环孢素和0.1%倍他米松滴眼液的比较:一项随机临床试验。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_919_25
Nirupama Varadhan, Krishnagopal Srikanth
{"title":"Comment on: Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial.","authors":"Nirupama Varadhan, Krishnagopal Srikanth","doi":"10.4103/IJO.IJO_919_25","DOIUrl":"10.4103/IJO.IJO_919_25","url":null,"abstract":"","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"468"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002214/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283433","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing combined trabeculotomy-trabeculectomy with gonioscopy-assisted transluminal trabeculotomy as primary surgery for primary congenital glaucoma. 小梁切开术联合小梁切除术与经腔镜辅助下小梁切开术治疗原发性先天性青光眼的比较。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_1813_25
Anand K Pathak, Viney Gupta, Anurag Kumar, Shikha Gupta

Purpose: The purpose of this study was to compare surgical outcomes and safety profiles of gonioscopy-assisted transluminal trabeculotomy (GATT) versus combined trabeculectomy and trabeculotomy (CTT) in primary congenital glaucoma (PCG) at 12 months.

Design: Retrospective comparative analysis.

Methods: Children with mild-to-moderate PCG who underwent either GATT or CTT between December 2021 and June 2023 were included. Patients' data recorded at baseline and at postoperative periods of 1st, 3rd, 6th, and 12th months were analyzed. Intraocular pressure (IOP) reduction, incidence of complications, and the need for repeat examinations under anesthesia (EUA) were analyzed. Surgical success was defined as absolute when IOP ≤18 (criterion A) and ≤15 mmHg (criterion B) was achieved without medications and qualified, when achieved with medications. Failure was defined as IOP >18 mmHg on maximal medical therapy, IOP <6 mmHg, or the need for additional IOP-lowering surgery. Multivariate regression analysis was used to assess baseline predictors for binary outcomes (surgical success and any complication).

Results: Ninety-eight eyes from 68 children diagnosed with PCG were analyzed, having undergone either CTT (58 eyes) or GATT (40 eyes) with 12-month follow-up, which showed similar success rates (P = 0.6, Log Rank test). Multivariate analysis did not identify any significant baseline predictors of surgical success. Postoperative complications (34% vs 20%; adjusted P = 0.02) and need for repeat EUAs (0 vs 1.27/eye; P = 0.05) were significantly higher in the CTT group.

Conclusions: In mild-moderate PCG eyes, GATT demonstrated similar surgical success with a better safety profile than CTT and can be preferred as the first-line surgical modality.

目的:本研究的目的是比较12个月原发性先天性青光眼(PCG)的手术效果和安全性,镜检辅助腔内小梁切开术(GATT)与联合小梁切除术和小梁切开术(CTT)。设计:回顾性比较分析。方法:纳入在2021年12月至2023年6月期间接受GATT或CTT治疗的轻中度PCG患儿。分析患者在基线和术后第1、3、6、12个月的数据。分析眼压(IOP)降低、并发症发生率和麻醉下重复检查的必要性。当IOP≤18(标准A)和≤15 mmHg(标准B)在没有药物治疗的情况下达到时,手术成功被定义为绝对成功;当有药物治疗时,手术成功被定义为合格。IOP结果:68例确诊为PCG的患儿中98只眼接受了CTT(58只眼)或GATT(40只眼),随访12个月,成功率相似(P = 0.6, Log Rank检验)。多变量分析没有发现任何显著的基线预测手术成功。CTT组术后并发症(34% vs 20%,校正P = 0.02)和需要重复EUAs (0 vs 1.27/眼,P = 0.05)显著高于CTT组。结论:在轻中度PCG眼中,GATT的手术成功率与CTT相似,安全性优于CTT,可作为首选的一线手术方式。
{"title":"Comparing combined trabeculotomy-trabeculectomy with gonioscopy-assisted transluminal trabeculotomy as primary surgery for primary congenital glaucoma.","authors":"Anand K Pathak, Viney Gupta, Anurag Kumar, Shikha Gupta","doi":"10.4103/IJO.IJO_1813_25","DOIUrl":"10.4103/IJO.IJO_1813_25","url":null,"abstract":"<p><strong>Purpose: </strong>The purpose of this study was to compare surgical outcomes and safety profiles of gonioscopy-assisted transluminal trabeculotomy (GATT) versus combined trabeculectomy and trabeculotomy (CTT) in primary congenital glaucoma (PCG) at 12 months.</p><p><strong>Design: </strong>Retrospective comparative analysis.</p><p><strong>Methods: </strong>Children with mild-to-moderate PCG who underwent either GATT or CTT between December 2021 and June 2023 were included. Patients' data recorded at baseline and at postoperative periods of 1st, 3rd, 6th, and 12th months were analyzed. Intraocular pressure (IOP) reduction, incidence of complications, and the need for repeat examinations under anesthesia (EUA) were analyzed. Surgical success was defined as absolute when IOP ≤18 (criterion A) and ≤15 mmHg (criterion B) was achieved without medications and qualified, when achieved with medications. Failure was defined as IOP >18 mmHg on maximal medical therapy, IOP <6 mmHg, or the need for additional IOP-lowering surgery. Multivariate regression analysis was used to assess baseline predictors for binary outcomes (surgical success and any complication).</p><p><strong>Results: </strong>Ninety-eight eyes from 68 children diagnosed with PCG were analyzed, having undergone either CTT (58 eyes) or GATT (40 eyes) with 12-month follow-up, which showed similar success rates (P = 0.6, Log Rank test). Multivariate analysis did not identify any significant baseline predictors of surgical success. Postoperative complications (34% vs 20%; adjusted P = 0.02) and need for repeat EUAs (0 vs 1.27/eye; P = 0.05) were significantly higher in the CTT group.</p><p><strong>Conclusions: </strong>In mild-moderate PCG eyes, GATT demonstrated similar surgical success with a better safety profile than CTT and can be preferred as the first-line surgical modality.</p>","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"451-457"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Performance and safety of reused Kahook dual blade (KDB) for combined cataract and minimally invasive glaucoma surgery in open-angle glaucoma". “开角型青光眼白内障联合微创青光眼手术中重复使用Kahook双刀片(KDB)的性能和安全性”综述。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_3042_25
Neethu Zacharia, Murali Ariga, Shwetha Parsawar
{"title":"Comment on \"Performance and safety of reused Kahook dual blade (KDB) for combined cataract and minimally invasive glaucoma surgery in open-angle glaucoma\".","authors":"Neethu Zacharia, Murali Ariga, Shwetha Parsawar","doi":"10.4103/IJO.IJO_3042_25","DOIUrl":"10.4103/IJO.IJO_3042_25","url":null,"abstract":"","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"464-465"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author's Response to comments on: "Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial". 作者对以下评论的回应:“小梁切除术后2.0%环孢素与0.1%倍他米松滴眼液的比较:一项随机临床试验”。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_2937_25
Ramin Daneshvar
{"title":"Author's Response to comments on: \"Comparison of postoperative cyclosporine 2.0% versus betamethasone 0.1% eye drops following trabeculectomy: A randomized clinical trial\".","authors":"Ramin Daneshvar","doi":"10.4103/IJO.IJO_2937_25","DOIUrl":"10.4103/IJO.IJO_2937_25","url":null,"abstract":"","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"468-469"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002218/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reuse of single-use Kahook dual blade: Safety and ethics. 一次性Kahook双刀片的再利用:安全与伦理。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_2626_25
Tarannum Mansoori
{"title":"Reuse of single-use Kahook dual blade: Safety and ethics.","authors":"Tarannum Mansoori","doi":"10.4103/IJO.IJO_2626_25","DOIUrl":"10.4103/IJO.IJO_2626_25","url":null,"abstract":"","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"465"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283591","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early outcomes of combined suture gonioscopy-assisted transluminal trabeculotomy and phacoemulsification in Indian eyes: A retrospective study. 联合缝线镜检辅助腔内小梁切开术联合超声乳化术治疗印度眼的早期疗效:回顾性研究。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-01-07 DOI: 10.4103/IJO.IJO_1290_25
Pooja Bhomaj, Rutul Patel, Tejaswi Pujari, Rameshwari Salunkhe

Purpose: To analyze early outcomes and safety profiles of combined phacoemulsification and suture gonioscopy-assisted transluminal trabeculotomy (phaco-GATT) in Indian eyes with primary and secondary (pseudoexfoliative) glaucoma coexisting with cataract.

Methods: In this retrospective interventional analysis, 42 eyes with primary and secondary (pseudoexfoliative) glaucoma, all with coexisting cataract having follow-up of 6 months to 1 year, were included. Phacoemulsification with suture GATT was performed. Outcome measures included surgical success rate (complete and qualified), intraocular pressure (IOP) reduction post surgery, change in antiglaucoma medications (AGMs) post surgery, change in best corrected visual acuity, and surgical complications. IOP reduction <18 mmHg or ≥30% from baseline without AGM was defined as complete success. IOP reduction <18 mmHg or ≥30% from baseline with AGM was considered as qualified success.

Results: Mean baseline IOP reduced significantly from 23.05+- 7.42 mmHg to 13.4+- 3.20 mmHg at 1 year ( P < 0.001, n = 30), with a 44% IOP reduction. Mean AGM use decreased from 1.93+- 0.52 to 0.13+-0.43 at 1 year ( P < 0.001, n = 30). The complete and qualified success rates at 1 year were 90% and 93%, respectively. BCVA improved from 0.533+- 0.36 logMAR to 0.013+-0.050 logMAR ( P < 0.001). Common complications were IOP spikes (19%) and transient hyphema (16%), all resolving without major intervention.

Conclusion: Combined phaco-GATT is a cost-effective and safe surgery with favorable early outcomes, providing significant IOP reduction, reduced medication burden, and minimal complications in patients with primary and secondary (pseudoexfoliative) glaucoma. As a conjunctiva sparing technique, it preserves future surgical options and may delay or avoid need for trabeculectomy.

目的:分析超声乳化术联合巩膜镜检辅助腔内小梁切开术(phaco-GATT)治疗原发性和继发性(假剥脱性)青光眼合并白内障的早期疗效和安全性。方法:回顾性介入分析42只伴有白内障的原发性和继发性(假剥脱性)青光眼,随访6个月至1年。采用GATT缝合行超声乳化术。结果测量包括手术成功率(完全和合格)、术后眼压(IOP)降低、术后抗青光眼药物(AGMs)的变化、最佳矫正视力的变化和手术并发症。IOP降低结果:平均基线IOP在1年后从23.05+- 7.42 mmHg显著降低到13.4+- 3.20 mmHg (P < 0.001, n = 30), IOP降低44%。1年后,AGM的平均使用率从1.93+- 0.52降至0.13+-0.43 (P < 0.001, n = 30)。1年的完全成功率为90%,合格成功率为93%。BCVA从0.533+- 0.36 logMAR改善到0.013+-0.050 logMAR (P < 0.001)。常见的并发症是IOP尖峰(19%)和短暂性前房积血(16%),均在没有重大干预的情况下消退。结论:phaco-GATT联合手术是一种经济有效且安全的手术,具有良好的早期预后,可显著降低IOP,减轻药物负担,并将原发性和继发性(假剥脱性)青光眼患者的并发症降到最低。作为一种保留结膜的技术,它保留了未来的手术选择,并可能延迟或避免小梁切除术的需要。
{"title":"Early outcomes of combined suture gonioscopy-assisted transluminal trabeculotomy and phacoemulsification in Indian eyes: A retrospective study.","authors":"Pooja Bhomaj, Rutul Patel, Tejaswi Pujari, Rameshwari Salunkhe","doi":"10.4103/IJO.IJO_1290_25","DOIUrl":"10.4103/IJO.IJO_1290_25","url":null,"abstract":"<p><strong>Purpose: </strong>To analyze early outcomes and safety profiles of combined phacoemulsification and suture gonioscopy-assisted transluminal trabeculotomy (phaco-GATT) in Indian eyes with primary and secondary (pseudoexfoliative) glaucoma coexisting with cataract.</p><p><strong>Methods: </strong>In this retrospective interventional analysis, 42 eyes with primary and secondary (pseudoexfoliative) glaucoma, all with coexisting cataract having follow-up of 6 months to 1 year, were included. Phacoemulsification with suture GATT was performed. Outcome measures included surgical success rate (complete and qualified), intraocular pressure (IOP) reduction post surgery, change in antiglaucoma medications (AGMs) post surgery, change in best corrected visual acuity, and surgical complications. IOP reduction <18 mmHg or ≥30% from baseline without AGM was defined as complete success. IOP reduction <18 mmHg or ≥30% from baseline with AGM was considered as qualified success.</p><p><strong>Results: </strong>Mean baseline IOP reduced significantly from 23.05+- 7.42 mmHg to 13.4+- 3.20 mmHg at 1 year ( P < 0.001, n = 30), with a 44% IOP reduction. Mean AGM use decreased from 1.93+- 0.52 to 0.13+-0.43 at 1 year ( P < 0.001, n = 30). The complete and qualified success rates at 1 year were 90% and 93%, respectively. BCVA improved from 0.533+- 0.36 logMAR to 0.013+-0.050 logMAR ( P < 0.001). Common complications were IOP spikes (19%) and transient hyphema (16%), all resolving without major intervention.</p><p><strong>Conclusion: </strong>Combined phaco-GATT is a cost-effective and safe surgery with favorable early outcomes, providing significant IOP reduction, reduced medication burden, and minimal complications in patients with primary and secondary (pseudoexfoliative) glaucoma. As a conjunctiva sparing technique, it preserves future surgical options and may delay or avoid need for trabeculectomy.</p>","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":" ","pages":"389-393"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002013/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145911308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Authors' reply: Reuse of single-use Kahook Dual Blade: Safety and ethics. 作者回复:一次性Kahook双刃的再利用:安全和伦理。
IF 1.8 4区 医学 Q2 OPHTHALMOLOGY Pub Date : 2026-03-01 Epub Date: 2026-02-26 DOI: 10.4103/IJO.IJO_2949_25
Sahebaan S Sethi, Aditya Sethi
{"title":"Authors' reply: Reuse of single-use Kahook Dual Blade: Safety and ethics.","authors":"Sahebaan S Sethi, Aditya Sethi","doi":"10.4103/IJO.IJO_2949_25","DOIUrl":"10.4103/IJO.IJO_2949_25","url":null,"abstract":"","PeriodicalId":13329,"journal":{"name":"Indian Journal of Ophthalmology","volume":"74 3","pages":"466-467"},"PeriodicalIF":1.8,"publicationDate":"2026-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13002219/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147283413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Ophthalmology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1